In Petition, Pfizer Takes Aim At Patented Propylene-Glycol Formulation
ALEXANDRIA, Va. — A Novo Nordisk patent relating to a formulation used in injection devices was "already disclosed" by prior art, Pfizer Inc. tells the Patent Trial and Appeal Board in...To view the full article, register now.
Already a subscriber? Click here to view full article